Nantong Jinghua Pharmaceutical Co. Ltd. | Ownership
Companies that own Nantong Jinghua Pharmaceutical Co. Ltd.
Atlantis Investment Management (Hong Kong) Ltd.
5,300,396
0.69%
5,300,396
2.49%
12/31/2017
China International Capital Corp. HK Asset Management Ltd.
2,013,874
0.26%
-2,672,044
0.92%
09/30/2017
Guotai Junan Allianz Fund Management Co., Ltd.
1,836,700
0.24%
1,836,700
0.09%
09/30/2017
Citigroup Global Markets Ltd. (Investment Management)
1,500,246
0.2%
1,500,246
3.21%
09/30/2017
GF Fund Management Co., Ltd.
204,000
0.03%
19,400
0%
12/31/2017
Tian Hong Asset Management Co., Ltd.
191,100
0.03%
51,700
0.01%
12/31/2017
HuaAn Fund Management Co., Ltd.
134,804
0.02%
0
0%
12/31/2017
China Southern Asset Management Co., Ltd.
8,000
0%
-400
0%
12/31/2017
Hwabao WP Fund Management Co., Ltd.
5,300
0%
-1,000
0%
12/31/2017
CCB Principal Asset Management Co., Ltd.
0
0%
-120
0%
12/31/2017
| Address |
No. 9 Xingtai Road
Nantong Jiangsu 226005
China
|
|
Employees
|
- |
| Website |
http://www.ntjhzy.com |
| Updated |
07/08/2019 |
| Nantong Jinghua Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceuticals as well as involves in the research, development and sale of active pharmaceutical ingredients and intermediaries. Its products include Alendronate sodium, Alendronic acid, Benzobarbital, Azelaic acid, Moxonidine, Lornoxicam, Meloxicam, Piroxicam, and Strontium ranelate. The company was founded on January 3, 1994 and is headquartered in Nantong, China. |
